查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386279

经导管主动脉瓣置换术 (TAVR) 市场报告：2030 年趋势、预测与竞争分析

Transcatheter Aortic Valve Replacement (TAVR) Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

经导管主动脉瓣置换术 (TAVR) 趋势与预测

预计到 2030 年，全球经导管主动脉瓣置换术 (TAVR) 市场将达到 198 亿美元，2024 年至 2030 年复合年增长率为 16.5%。该市场的主要驱动因素是主动脉瓣狭窄病例数量的增加、瓣膜置换术微创手术的需求不断增长以及 TAVR 设备的持续技术进步。全球经导管主动脉瓣置换术（TAVR）市场未来性广阔，医院市场和门诊手术中心市场机会庞大。

经导管主动脉瓣置换术 (TAVR) 市场洞察

Lucintel 预测无缝线瓣膜在预测期内将出现高速成长。

预计北美地区在预测期内将出现最高的成长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球经导管主动脉瓣置换术（TAVR）市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球经导管主动脉瓣置换术（TAVR）市场趋势（2018-2023）与预测（2024-2030）
  • 按产品类型分類的全球经导管主动脉瓣置换术 (TAVR) 市场
    • 经导管主动脉瓣
    • 无缝线瓣膜
    • 其他的
  • 按材料分類的全球经导管主动脉瓣置换术 (TAVR) 市场
    • 不銹钢
    • 镍钛合金
    • 钴铬合金
    • 其他的
  • 以最终用途分類的全球经导管主动脉瓣置换术 (TAVR) 市场
    • 医院
    • 门诊手术中心
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球经导管主动脉瓣置换术（TAVR）市场（按地区）
  • 北美经导管主动脉瓣置换术 (TAVR) 市场
  • 欧洲经导管主动脉瓣置换术（TAVR）市场
  • 亚太地区经导管主动脉瓣置换术 (TAVR) 市场
  • 其他地区经导管主动脉瓣置换术（TAVR）市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球经导管主动脉瓣置换术 (TAVR) 市场成长机会
    • 全球经导管主动脉瓣置换术 (TAVR) 市场材料成长机会
    • 全球经导管主动脉瓣置换术 (TAVR) 市场成长机会（以最终用途）
    • 全球经导管主动脉瓣置换术 (TAVR) 市场成长机会（按地区）
  • 全球经导管主动脉瓣置换术 (TAVR) 市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球经导管主动脉瓣置换术 (TAVR) 市场容量扩张
    • 全球经导管主动脉瓣置换术 (TAVR) 市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • CryoLife
  • Abbott
  • Micro Interventional Devices
  • Boston Scientific
  • LivaNova
  • Meril Life Sciences
  • Edwards Lifesciences
简介目录

Transcatheter Aortic Valve Replacement (TAVR) Trends and Forecast

The future of the global transcatheter aortic valve replacement (TAVR) market looks promising with opportunities in the hospital and ambulatory surgical centre markets. The global transcatheter aortic valve replacement (TAVR) market is expected to reach an estimated $19.8 billion by 2030 with a CAGR of 16.5% from 2024 to 2030. The major drivers for this market are rising cases of aortic stenosis, growing demand for minimally invasive procedures for valve replacement, and continuos technological advancements in TAVR devices.

A more than 150-page report is developed to help in your business decisions.

Transcatheter Aortic Valve Replacement (TAVR) by Segment

The study includes a forecast for the global transcatheter aortic valve replacement (TAVR) by product type, material, end use, and region.

Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Transcatheter Aortic Valve
  • Sutureless Valve
  • Others

Transcatheter Aortic Valve Replacement (TAVR) Market by Material [Shipment Analysis by Value from 2018 to 2030]:

  • Stainless Steel
  • Nitinol
  • Cobalt Chromium
  • Others

Transcatheter Aortic Valve Replacement (TAVR) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Ambulatory Surgical Centres
  • Others

Transcatheter Aortic Valve Replacement (TAVR) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Transcatheter Aortic Valve Replacement (TAVR) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies transcatheter aortic valve replacement (TAVR) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transcatheter aortic valve replacement (TAVR) companies profiled in this report include-

  • CryoLife
  • Abbott
  • Micro Interventional Devices
  • Boston Scientific
  • LivaNova
  • Meril Life Sciences
  • Edwards Lifesciences

Transcatheter Aortic Valve Replacement (TAVR) Market Insights

Lucintel forecasts that sutureless valve is expected to witness higher growth over the forecast period.

North America is expected to witness highest growth over the forecast period.

Features of the Global Transcatheter Aortic Valve Replacement (TAVR) Market

Market Size Estimates: Transcatheter aortic valve replacement (TAVR) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Transcatheter aortic valve replacement (TAVR) market size by product type, material, end use, and region in terms of value ($B).

Regional Analysis: Transcatheter aortic valve replacement (TAVR) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, materials, end uses, and regions for the transcatheter aortic valve replacement (TAVR) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transcatheter aortic valve replacement (TAVR) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the transcatheter aortic valve replacement (TAVR) market size?

Answer: The global transcatheter aortic valve replacement (TAVR) market is expected to reach an estimated $19.8 billion by 2030.

Q.2 What is the growth forecast for transcatheter aortic valve replacement (TAVR) market?

Answer: The global transcatheter aortic valve replacement (TAVR) market is expected to grow with a CAGR of 16.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the transcatheter aortic valve replacement (TAVR) market?

Answer: The major drivers for this market are rising cases of aortic stenosis, growing demand for minimally invasive procedures for valve replacement, and continuos technological advancements in TAVR devices.

Q4. What are the major segments for transcatheter aortic valve replacement (TAVR) market?

Answer: The future of the transcatheter aortic valve replacement (TAVR) market looks promising with opportunities in the hospital and ambulatory surgical centre markets.

Q5. Who are the key transcatheter aortic valve replacement (TAVR) market companies?

Answer: Some of the key transcatheter aortic valve replacement (TAVR) companies are as follows:

  • CryoLife
  • Abbott
  • Micro Interventional Devices
  • Boston Scientific
  • LivaNova
  • Meril Life Sciences
  • Edwards Lifesciences

Q6. Which transcatheter aortic valve replacement (TAVR) market segment will be the largest in future?

Answer: Lucintel forecasts that sutureless valve is expected to witness higher growth over the forecast period.

Q7. In transcatheter aortic valve replacement (TAVR) market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the transcatheter aortic valve replacement (TAVR) market by product type (transcatheter aortic valve, sutureless valve, and others), material (stainless steel, nitinol, cobalt chromium, and others), end use (hospitals, ambulatory surgical centres, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Transcatheter Aortic Valve Replacement (TAVR) Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Transcatheter Aortic Valve Replacement (TAVR) Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type
    • 3.3.1: Transcatheter Aortic Valve
    • 3.3.2: Sutureless Valve
    • 3.3.3: Others
  • 3.4: Global Transcatheter Aortic Valve Replacement (TAVR) Market by Material
    • 3.4.1: Stainless Steel
    • 3.4.2: Nitinol
    • 3.4.3: Cobalt Chromium
    • 3.4.4: Others
  • 3.5: Global Transcatheter Aortic Valve Replacement (TAVR) Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Ambulatory Surgical Centres
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Transcatheter Aortic Valve Replacement (TAVR) Market by Region
  • 4.2: North American Transcatheter Aortic Valve Replacement (TAVR) Market
    • 4.2.2: North American Transcatheter Aortic Valve Replacement (TAVR) Market by End Use: Hospitals, Ambulatory Surgical Centres, and Others
  • 4.3: European Transcatheter Aortic Valve Replacement (TAVR) Market
    • 4.3.1: European Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type: Transcatheter Aortic Valve, Sutureless Valve, and Others
    • 4.3.2: European Transcatheter Aortic Valve Replacement (TAVR) Market by End Use: Hospitals, Ambulatory Surgical Centres, and Others
  • 4.4: APAC Transcatheter Aortic Valve Replacement (TAVR) Market
    • 4.4.1: APAC Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type: Transcatheter Aortic Valve, Sutureless Valve, and Others
    • 4.4.2: APAC Transcatheter Aortic Valve Replacement (TAVR) Market by End Use: Hospitals, Ambulatory Surgical Centres, and Others
  • 4.5: ROW Transcatheter Aortic Valve Replacement (TAVR) Market
    • 4.5.1: ROW Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type: Transcatheter Aortic Valve, Sutureless Valve, and Others
    • 4.5.2: ROW Transcatheter Aortic Valve Replacement (TAVR) Market by End Use: Hospitals, Ambulatory Surgical Centres, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Transcatheter Aortic Valve Replacement (TAVR) Market by Material
    • 6.1.3: Growth Opportunities for the Global Transcatheter Aortic Valve Replacement (TAVR) Market by End Use
    • 6.1.4: Growth Opportunities for the Global Transcatheter Aortic Valve Replacement (TAVR) Market by Region
  • 6.2: Emerging Trends in the Global Transcatheter Aortic Valve Replacement (TAVR) Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Transcatheter Aortic Valve Replacement (TAVR) Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transcatheter Aortic Valve Replacement (TAVR) Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: CryoLife
  • 7.2: Abbott
  • 7.3: Micro Interventional Devices
  • 7.4: Boston Scientific
  • 7.5: LivaNova
  • 7.6: Meril Life Sciences
  • 7.7: Edwards Lifesciences